Nerve Repair & Regeneration Market Scope, Growth, Size and Share by 2028
Nerve Repair & Regeneration Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 6.61 Billion |
Market Size by 2028 | US$ 12.51 Billion |
Global CAGR (2021 - 2028) | 9.7% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
The COVID-19 pandemic had a mixed impact on the nerve repair & regeneration market. In the first quarter of 2020, the lockdown restrictions limited the nerve injury cases, due to which there had been a reduction in the demand for biomaterials for nerve repair surgical procedures. Vehicular accidents are the most common cause of peripheral nerve injuries, but during the lockdown, nerve injuries were less owing to limited movement. However, the U.S. Department of Health & Human Services reported that in 2020, a nearly 17 percent increase was observed in deaths from accidents or unintentional injuries in the United States after the lockdown was lifted. It also reported that accidents were the 4th leading cause of death in 2020, with only 150,000 deaths below COVID-19 deaths. These deaths were observed because of the delays in the surgical procedures for accidental cases owing to the COVID-19 safety protocols. Furthermore, after the first quarter of 2020, the market saw growth at an average rate due to the rising treatment and surgical procedures for nerve injuries.
Based on geography, the global nerve repair & regeneration market is primarily segmented into North America, Europe, Asia Pacific, Middle East and Africa (MEA), and South and Central America. The market in North America is further segmented into the US, Canada, and Mexico. The European market is subsegmented into France, Germany, the UK, Spain, Italy, and the Rest of Europe. The market in Asia Pacific is subsegmented into Japan, China, India, Australia, South Korea, and the Rest of APAC. The nerve repair & regeneration market in the MEA is further segmented into Saudi Arabia, the UAE, South Africa, and the Rest of MEA. The market in South and Central America is subsegmented into Brazil, Argentina, and the Rest of South and Central America.
Few companies in the global nerve repair & regeneration market are Axogen Corporation, Boston Scientific Corporation, Integra LifeSciences, Medtronic, Abbott Laboratories, Stryker Corporation, Neuronetics, LivaNova PLC, Baxter, and Polyganics BV.